News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Submit Your Abstract for EIOC2025 and Receive Priority Review – EIOC
EIOC/LinkedIn
Jun 7, 2025, 08:05

Submit Your Abstract for EIOC2025 and Receive Priority Review – EIOC

 Excellence in Oncology Care (EIOC) shared a post on LinkedIn:

“Be among the first 100 abstract submissions to EIOC2025 and receive priority review by our esteemed Scientific Committee. Don’t miss your chance to fast-track your work to the forefront of oncology care! Submit now.”

cancer EIOC EIOC2025 Excellence in Oncology Care OncoDaily Oncology
Special Coverage
Drugs
Jun 7, 2025, 15:16
Komal Jhaveri: Novel Endocrine Therapies and Targeted Therapies for HR+ HER2- Breast Cancer
Blog
Jun 7, 2025, 15:13
Jasmine Kamboj Highlights Rural Oncology Conference and Thanks Co-Founders for Successful Event
Blog
Jun 7, 2025, 14:53
Amol Akhade Shared Treatment Algorithm for HR +/Her2 -mBC from ASCO25
Blog
Jun 7, 2025, 14:44
SPCC Will Host Webinar on Early Nutrition Screening and Intervention in Cancer Care
Insight
Jun 7, 2025, 14:38
Paolo Tarantino: Thanks to NSABP-B51, Countless Patients Will Be Spared the Toxicity of Nodal Irradiation
Blog
Jun 7, 2025, 14:12
Vinod Balachandran on Pancreatic Cancer and Its Prognosis - Memorial Sloan Kettering Cancer Center
Insight
Jun 7, 2025, 14:10
Childhood Cancer International Receives $50,000 Donation from MKA Group
Blog
Jun 7, 2025, 14:03
Nina Niu Sanford: The Simultaneous ASCO 2025 Presentation and Pubs Were Great
Blog
Jun 7, 2025, 13:44
Luis E. Raez: Florida CCRAB Meeting Focuses on New Florida Cancer Control Plan
Blog
Jun 7, 2025, 13:19
Caterina Sposetti: ASCO25 Was Filled With Science, Inspiration, and Meaningful Connections
Blog
Jun 7, 2025, 12:46
Alexandre Chan: Can a Team-based Approach Transform Cancer Survivorship Care?
Blog
Jun 7, 2025, 12:39
Drew Moghanaki: SAFRON II Was a "SABR in Lieu of Systemic Therapy" Study for Lung Metastases